PMA Supplement Modifications Guidance Released By FDA June 9
This article was originally published in The Gray Sheet
Executive SummaryPremarket approval application supplements for changes made to a legally marketed device as a result of a recall or corrective action will be given "priority" review, FDA says in a draft guidance document for use in determining when device modifications require PMA supplements.
You may also be interested in...
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.